The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The prognostic value of neutrophil-to-lymphocyte ratio in patients with epidermal growth factor receptor mutated advanced non-small cell lung cancer (NSCLC).
 
Nicole Yun
No Relationships to Disclose
 
Sherin Juliet Rouhani
No Relationships to Disclose
 
Brendan Gilmore
Honoraria - AstraZeneca
Consulting or Advisory Role - Boehringer Ingelheim
 
Ethan M. Ritz
No Relationships to Disclose
 
Christine M. Bestvina
Consulting or Advisory Role - Abbvie; AstraZeneca; Genentech; Pfizer
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - EMD Serono
 
Imad Tarhoni
Travel, Accommodations, Expenses - Luminex
 
Marta Batus
No Relationships to Disclose
 
Jeffrey Allen Borgia
Honoraria - Luminex
Consulting or Advisory Role - Luminex
Speakers' Bureau - Luminex
Research Funding - Abbott; Biodesix; Epigenomics; Pfizer
Travel, Accommodations, Expenses - Luminex
(OPTIONAL) Uncompensated Relationships - MilliporeSigma
 
Philip D. Bonomi
Honoraria - AstraZeneca; Biodesix; Helsinn Therapeutics; Merck; pfizer; Spectrum Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; Biodesix; Helsinn Therapeutics; Merck; Merck; Pfizer
Research Funding - AstraZeneca (Inst); Biodesix (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Five Prime Therapeutics (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Mary J. Fidler
Honoraria - AstraZeneca
Consulting or Advisory Role - Abbvie (I); AstraZeneca; Genentech; Genentech (I); Guardant Health; Guardant Health; Rakuten Medical (Inst)
Speakers' Bureau - Genentech; Merck
Research Funding - AstraZeneca (Inst); Biodesix; CytomX Therapeutics (Inst); Jounce Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer/EMD Serono; Rakuten Medical (Inst)